Andrew Hyman - Chief Operating Officer and General Counsel
Location
New York, NY
Holdings as of
31 Dec 2017
Value $
$169,055,000
Num holdings
5
Filing time
14 Feb 2018, 10:34:29 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included AEGERION PHARMACEUTICALS INC, VIVUS INC, PTC THERAPEUTICS INC, SUCAMPO PHARMACEUTICALS INC, and APEN.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Andrew Hyman
Chief Operating Officer and General Counsel
New York, New York
14 Feb 2018
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.